INCLINE VILLAGE, Nev.,
July 31, 2017 /PRNewswire/
-- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI)
today announced that the Company will release its second quarter
financial results for the period ended June
30, 2017, on Thursday, August 3,
2017, after market close. PDL's management will host a
conference call and webcast that day at 4:30
p.m. Eastern Time to discuss the financial results. A slide
presentation relating to the call will be available via the webcast
link on the PDL website.
Conference Call Details
To access the live conference call via phone, please dial (800)
668-4132 from the United States
and Canada or (224) 357-2196
internationally. The conference ID is 51927827. Please dial in
approximately 10 minutes prior to the start of the call. A
telephone replay will be available for one week following the call
and may be accessed by dialing (855) 859-2056 from the United States and Canada or (404) 537-3406 internationally. The
replay passcode is 51927827.
To access the live and subsequently archived webcast of the
conference call, go to the Company's website at http://www.pdl.com
and go to "Events & Presentations." Please connect to the
website at least 15 minutes prior to the call to allow for any
software download that may be necessary.
About PDL BioPharma
PDL seeks to provide a significant return for its shareholders by
acquiring and managing a portfolio of companies, products, royalty
agreements and debt facilities in the biotech, pharmaceutical and
medical device industries. In late 2012, PDL began providing
alternative sources of capital through royalty monetizations and
debt facilities and in 2016, began making equity investments in
commercial stage companies, the first being Noden Pharma DAC.
PDL has committed over $1.4 billion and funded
approximately $1.1 billion in these investments and has
two operating companies as subsidiaries, Noden Pharma DAC and
LENSAR, Inc. PDL is headquartered in Incline Village,
Nevada.
For more information, please visit www.pdl.com. PDL, PDL
BioPharma, the PDL logo and the PDL BioPharma logo are trademarks
or registered trademarks of, and are proprietary, to PDL BioPharma,
Inc. which reserves all rights therein.
Contacts:
|
|
Peter
Garcia
|
Jennifer
Williams
|
PDL BioPharma,
Inc.
|
Cook Williams
Communications, Inc.
|
775-832-8500
|
360-668-3701
|
peter.garcia@pdl.com
|
jennifer@cwcomm.org
|
View original
content:http://www.prnewswire.com/news-releases/pdl-biopharma-to-announce-second-quarter-2017-financial-results-on-august-3-2017-300496377.html
SOURCE PDL BioPharma, Inc.